Search alternatives:
teer decrease » greater decrease (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 500 ms (Expand Search), 50 mg (Expand Search), 50 mm (Expand Search)
teer decrease » greater decrease (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 500 ms (Expand Search), 50 mg (Expand Search), 50 mm (Expand Search)
-
12341
-
12342
Anion Complexes with Tetrazine-Based Ligands: Formation of Strong Anion−π Interactions in Solution and in the Solid State
Published 2016“…The importance of desolvation phenomena manifested by such thermodynamic data was confirmed by the hydrodynamic results obtained by means of diffusion NMR spectroscopy. In the case of <b>L2</b>, complexation equilibria were also studied in a 80:20 (v/v) water/ethanol mixture. …”
-
12343
-
12344
-
12345
-
12346
-
12347
-
12348
-
12349
-
12350
-
12351
-
12352
Electrochemical Synthesis of the Energetic Combustion Catalyst Co(BODN)·9H<sub>2</sub>O and Its Catalytic Effect on Ammonium Perchlorate Thermal Decomposition
Published 2023“…Safe, efficient, and green synthetic energetic combustion catalysts are of great importance for the application of ammonium perchlorate (AP) in solid propellants. In this study, a novel, simple, efficient, and green electrochemical method for synthesizing energetic combustion catalysts was designed and implemented to successfully synthesize Co(BODN)·9H<sub>2</sub>O (BODN = [2,2′-bi{1,3,4-oxadiazole}]-5,5′-dinitramide), a novel energetic combustion catalyst. …”
-
12353
-
12354
-
12355
-
12356
-
12357
-
12358
-
12359
-
12360
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopi...
Published 2024“…At v10 versus v2, the percentages of CD4+ interleukin-producing cells showed a decreasing trend in ISF L and NL, unbound IL-4 levels in plasma were increased, IL-5 levels in ISF L reduced, and levels of factors involved in anti-inflammatory pathways and re-epithelization increased. …”